Trig Smith
Email PDF
We aggressively pursue allegations of securities fraud with the highest levels of professional ethics.
Trig Smith is a partner in Robbins Geller Rudman & Dowd LLP's San Diego office where he focuses his practice on complex securities litigation. He has been involved in the prosecution of numerous securities class actions that have resulted in over a billion dollars in recoveries for investors. His cases have included: In re Cardinal Health, Inc. Sec. Litig. ($600 million recovery); Jones v. Pfizer Inc. ($400 million recovery); Silverman v. Motorola, Inc. ($200 million recovery); and City of Livonia Emps.' Ret. Sys. v. Wyeth ($67.5 million). Most recently, he was a member of the Firm's trial team in Hsu v. Puma Biotechnology, Inc., a securities fraud class action that resulted in a verdict in favor of investors after a two-week jury trial.
Trig received a Bachelor of Science degree and Master of Science degree from the University of Colorado. He earned his Juris Doctor degree from Brooklyn Law School where he was a member of the Brooklyn Journal of International Law, which published his note entitled: The S.E.C. and Foreign Private Issuers, 26 Brook. J. Int'l L. 765 (2000).
Brooklyn Law School, J.D., 2000
Member, Brooklyn Journal of International Law
University of Colorado, Denver, M.S., 1997
University of Colorado, Denver, B.S., 1995
United States Courts of Appeals for the Fourth and Ninth Circuits
United States District Courts for the Central and Southern Districts of California
United States District Court for the District of Colorado
Hsu v. Puma Biotechnology
In re Cardinal Health, Inc. Sec. Litig.
Jones v. Pfizer Inc.
Silverman v. Motorola, Inc.
Robbins Geller Defeats Motions to Dismiss in SPAC Securities Class Action
Robbins Geller Defeats Motion to Dismiss in COVID-19 Vaccine Securities Class Action
Robbins Geller Defeats Motion to Dismiss for Immunomedics, Inc. Investors
Robbins Geller Rudman & Dowd LLP Announces Plaintiff's Verdict in Securities Class Action Trial Against Puma Biotechnology, Inc. and Its Ceo, Alan H. Auerbach
Robbins Geller Achieves $400 Million Recovery for Pfizer Inc. Shareholders
Robbins Geller Recovers $400 Million for Pfizer Inc. Shareholders
Robbins Geller Rudman & Dowd LLP Announces Opening of Chicago Office and Recovery of $200 Million for Motorola Shareholders
Motorola Shareholders Obtain $200 Million Recovery in the Seventh Circuit